252 related articles for article (PubMed ID: 32804611)
41. Prognostic factors in hospitalized patients diagnosed with SARS-CoV-2 infection, Bogotá, Colombia.
Motta JC; Novoa DJ; Gómez CC; Moreno JM; Vargas L; Pérez J; Millán H; Arango ÁI
Biomedica; 2020 Oct; 40(Supl. 2):116-130. PubMed ID: 33152195
[TBL] [Abstract][Full Text] [Related]
42. Factors significantly associated with COVID-19 severity in symptomatic patients: A retrospective single-center study.
Hirashima T; Arai T; Kitajima H; Tamura Y; Yamada T; Hashimoto S; Morishita H; Minamoto S; Kawashima K; Kashiwa Y; Kameda M; Takeshita T; Suzuki H; Matsuoka H; Yamaguchi S; Tanaka T; Nagai T
J Infect Chemother; 2021 Jan; 27(1):76-82. PubMed ID: 33051144
[TBL] [Abstract][Full Text] [Related]
43. We urgently need guidelines for managing COVID-19 in children with comorbidities.
Dayal D
Acta Paediatr; 2020 Jul; 109(7):1497-1498. PubMed ID: 32279351
[TBL] [Abstract][Full Text] [Related]
44. The characterization of chronic rhinosinusitis in hospitalized patients with COVID-19.
Wang H; Song J; Pan L; Yao Y; Deng YK; Wang ZC; Liao B; Ma J; He C; Zeng M; Liu Z
J Allergy Clin Immunol Pract; 2020; 8(10):3597-3599.e2. PubMed ID: 32980581
[No Abstract] [Full Text] [Related]
45. Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda.
Kirenga B; Muttamba W; Kayongo A; Nsereko C; Siddharthan T; Lusiba J; Mugenyi L; Byanyima RK; Worodria W; Nakwagala F; Nantanda R; Kimuli I; Katagira W; Bagaya BS; Nasinghe E; Aanyu-Tukamuhebwa H; Amuge B; Sekibira R; Buregyeya E; Kiwanuka N; Muwanga M; Kalungi S; Joloba ML; Kateete DP; Byarugaba B; Kamya MR; Mwebesa H; Bazeyo W
BMJ Open Respir Res; 2020 Sep; 7(1):. PubMed ID: 32900781
[TBL] [Abstract][Full Text] [Related]
46. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome.
Roncon L; Zuin M; Rigatelli G; Zuliani G
J Clin Virol; 2020 Jun; 127():104354. PubMed ID: 32305882
[TBL] [Abstract][Full Text] [Related]
47. Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients.
Klopfenstein T; Zayet S; Lohse A; Selles P; Zahra H; Kadiane-Oussou NJ; Toko L; Royer PY; Balblanc JC; Gendrin V; Conrozier T;
Int J Infect Dis; 2020 Oct; 99():491-495. PubMed ID: 32798660
[TBL] [Abstract][Full Text] [Related]
48. Antiviral agents, glucocorticoids, antibiotics, and intravenous immunoglobulin in 1142 patients with coronavirus disease 2019: a systematic review and meta-analysis.
Pei L; Zhang S; Huang L; Geng X; Ma L; Jiang W; Li W; Chen D
Pol Arch Intern Med; 2020 Sep; 130(9):726-733. PubMed ID: 32749826
[TBL] [Abstract][Full Text] [Related]
49. Worrying situation regarding the use of dexamethasone for COVID-19.
Lim MA; Pranata R
Ther Adv Respir Dis; 2020; 14():1753466620942131. PubMed ID: 32684095
[No Abstract] [Full Text] [Related]
50. Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study.
Pagnesi M; Inciardi RM; Lombardi CM; Agostoni P; Ameri P; Barbieri L; Bellasi A; Camporotondo R; Canale C; Carubelli V; Carugo S; Catagnano F; Dalla Vecchia LA; Danzi GB; Di Pasquale M; Gaudenzi M; Giovinazzo S; Gnecchi M; Guazzi M; Iorio A; La Rovere MT; Leonardi S; Maccagni G; Mapelli M; Margonato D; Merlo M; Monzo L; Mortara A; Nuzzi V; Piepoli M; Porto I; Pozzi A; Sarullo F; Sinagra G; Tedino C; Tomasoni D; Volterrani M; Zaccone G; Senni M; Metra M
Int J Infect Dis; 2021 Jul; 108():270-273. PubMed ID: 34052406
[TBL] [Abstract][Full Text] [Related]
51. Body temperature correlates with mortality in COVID-19 patients.
Tharakan S; Nomoto K; Miyashita S; Ishikawa K
Crit Care; 2020 Jun; 24(1):298. PubMed ID: 32503659
[No Abstract] [Full Text] [Related]
52. The effect of glucocorticoids on mortality in severe COVID-19 patients: Evidence from 13 studies involving 6612 cases.
Yu GQ; Jiang ZH; Yang ZB; Jiang SQ; Quan XQ
Medicine (Baltimore); 2021 Oct; 100(40):e27373. PubMed ID: 34622840
[TBL] [Abstract][Full Text] [Related]
53. Discriminant Accuracy of the SOFA Score for Determining the Probable Mortality of Patients With COVID-19 Pneumonia Requiring Mechanical Ventilation.
Raschke RA; Agarwal S; Rangan P; Heise CW; Curry SC
JAMA; 2021 Apr; 325(14):1469-1470. PubMed ID: 33595630
[TBL] [Abstract][Full Text] [Related]
54. Glucocorticoids as a Double-Edged Sword in the Treatment of COVID-19: Mortality and Severity of COVID-19 in Patients Receiving Long-Term Glucocorticoid Therapy.
Cho EH
Endocrinol Metab (Seoul); 2023 Apr; 38(2):223-225. PubMed ID: 37150517
[No Abstract] [Full Text] [Related]
55. Early Childhood COVID-19: A Comparative Report of 20,506 Cases.
Zamani R; Zare A; Davoodi SZ; Shati M; Eshaghi H; Faramarzinia A; Mirjamali N; Barekati SH; Lornejad H
Pediatr Infect Dis J; 2023 Aug; 42(8):e293-e295. PubMed ID: 37171970
[TBL] [Abstract][Full Text] [Related]
56. Systemic consequences of COVID-19 infection in patients requiring mechanical ventilation: a 12-month prospective study.
Bongiovanni M; Zanini U; Bodini BD; Corbetta E; Bini F
Infection; 2023 Apr; 51(2):537-539. PubMed ID: 36125627
[No Abstract] [Full Text] [Related]
57. Prevention of Scarring of Lung Parenchyma in COVID-19 Patients through Glucocorticoid Treatment.
Bozkurt N; Yalcin AN
Am J Health Behav; 2023 Feb; 47(1):182-193. PubMed ID: 36945083
[No Abstract] [Full Text] [Related]
58. Is high-dose glucocorticoid beneficial in COVID-19?
Muthu V; Sehgal IS; Prasad KT; Agarwal R
Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33509962
[TBL] [Abstract][Full Text] [Related]
59. Reply: Is high-dose glucocorticoid beneficial in COVID-19?
Edalatifard M; Akhtari M; Salehi M; Farhadi E; Jamshidi A; Mahmoudi M; Rostamian A
Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33602862
[TBL] [Abstract][Full Text] [Related]
60. Inhaled glucocorticoids in treatment of covid-19.
Sova M; Zela O
Vnitr Lek; 2021; 67(6):328-329. PubMed ID: 35459373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
